Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
evidence of the efficacy of bevacizumab in patients with HHT.Both cases also show that symptoms and transfusion requirements improve with this therapy, without an appreciable change in arteriovenous malformations.Like Oosting et al., we found no difference in the size of our patient's pulmonary arteriovenous malformations on CT before and after bevacizumab.Their experience demonstrates the long-term safety and tolerability of bevacizumab in such patients.Our patient continues to report symptomatic benefit more than a year after completing therapy, and he has required only one intravenous infusion of iron during this time.His hemoglobin levels have remained stable at 14 to 15 g per deciliter.The cost of our patient's regimen (a total of 30 mg per kilogram over four cycles) would be approximately $12,000 today.The costs of continuing the drug in the long term, especially without a Food and Drug Administration-approved indication, would be prohibitive.Our case shows that intermittent dosing allows for long-term, symptomatic improvement and stability of pulmonary arteriovenous malformations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this patient, RDN resulted in a progressive decrease in blood pressure from 161/107 mmHg at baseline to 127/81 mmHg at 12-month follow-up.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“However, RDN-induced reductions in MSNA18 and beneficial effects of RDN on conditions that are not traditionally thought to be driven by the kidney, including heart failure and arrthymia19, cannot be wholly explained by alterations in body fluid homeostasis.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“ablation of the renal nerves was also associated with a substantial decrease in muscle sympathetic nerve activity (MSNA), from 56 bursts per minute before RDN to 19 bursts per minute at 12 months after the procedure.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“The hypothesis that renal afferents mediate some of the BP effects of RDN in humans was sparked by the finding that whole-body noradrenaline spillover and MSNA were decreased in a single patient 1 year after RDN170.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [170]
Citations
Cites
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Self-citationNeural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Schlaich, M. P., Lambert, E., Kaye, D. M., Krozowski, Z., Campbell, D. J., Lambert, G., Hastings, J., Aggarwal, A., & Esler, M. D. (2004) · Hypertension · doi:10.1161/01.hyp.0000103160.35395.9e · Cited by 514
Self-citationNoradrenaline Release and the Pathophysiology of Primary Human Hypertension
Esler, M., Jennings, G., & Lambert, G. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.3.140s · Cited by 138
Self-citation
Cited by
Items 601–700 of 763
Tvilsom effekt av renal denervering
Mariampillai, J. E., Elmula, F. E. M. F., Hoffmann, P., Sørensen, H., Høieggen, A., & Kjeldsen, S. E. (2014) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.14.0900 · Cited by 1
The Autonomic Cardiorenal Crosstalk: Pathophysiology and Implications for Heart Failure Management
Costanzo, M. R., & Gronda, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-24993-3_10 · Cited by 1
Armaganijan, L., Staico, R., Moreira, D. A. R., Amodeo, C., Borelli, F. A. D. O., de Sousa, M. G., Sousa, A., & Abizaid, A. (2014) · Revista Brasileira de Cardiologia Invasiva (English Edition) · doi:10.1016/s2214-1235(15)30010-7 · Cited by 1
Renal denervation: will the Phoenix rise from the ashes?
Messerli, F. H., & Bangalore, S. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx534 · Cited by 1
“The present working hypothesis pertaining to the underlying mechanisms of RDN is that the procedure interrupts sympathetic fibres and reduces norepinephrine levels.(9,10) One should also consider that irreversible changes may have occurred in a vascular tree that has been exposed to the ravages of hypertension for yea…”
BackgroundZeng, L., Zhang, Z., Yang, K., Jiang, F., Yuan, H., Tang, X., Jiang, W., & Wang, X. (2017) · Interventional Cardiology Journal · doi:10.21767/2471-8157.100067 · Cited by 1
The denervation or activation of renal sympathetic nerve and renal blood flow
Kharazmi, F., Hosseini-Dastgerdi, H., Pourshanazari, A., & Nematbakhsh, M. (2023) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_216_23 · Cited by 4
“[75] However, a case report indicated that RSDN was associated with increased RPF. [76] In Wistar Kyoto (WKY) and SHR, acute renal denervation under genetic control resulted in continuous diuresis and natriuresis in SHR and not in WKY, and there was no significant change in RBF. [77] Also, in SD…”
BackgroundAn Update on the Role of Renal Artery Denervation in the Treatment of Hypertension
Mewaldt, C., Crawford, E., Cluett, J., Arvanitis, L. V., Kentoffio, K., Secemsky, E. A., & Krawisz, A. K. (2024) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-024-01063-1 · Cited by 2
“Based on promising blood pressure reductions in these animal models and historical benefit among patients undergoing more extensive sympa-thectomy, a first-in-human minimally invasive RDN was performed by Schlaich and colleagues in 2009 [39].”
Ramezani, P., Amiri, M., Bagheri, A., & Naderi, F. (2024) · Jundishapur Journal of Health Sciences · doi:10.5812/jjhs-157051 · Cited by 1
Physiological Rationale for Renal Denervation Therapy in Hypertension
Ram, C. V. S., & Kumar, A. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5223-1_2 · Cited by 1
Pathophysiology: The Target for Renal Denervation
Böhm, M., Linz, D., Ukena, C., & Mahfoud, F. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5223-1_1 · Cited by 1
Neuroadrenergic abnormalities in hypertension and hypertension-related cardiovascular disease
Grassi, G. M. (2013) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2013.03.001 · Cited by 3
Treating refractory hypertension: Renal denervation with high-resolution 3d-angiography
Alegría‐Barrero, E., Teijeiro, R., Casares, M., Vega, M., Blázquez, M. A., Martos, R., Diego, C. D., Moreno, R., & Martin, M. S. (2013) · Research in Cardiovascular Medicine · doi:10.5812/cardiovascmed.9700 · Cited by 1
“Endovascular treatment with low dose radiofrequency in the renal arteries (renal denervation) has shown to be effective reducing sympathetic activation of efferent nerves, involved in hypertensive responses (6-9).”
BackgroundRomanov, A. B., Pokushalov, Y. A., Анатольевич, З. Д., Dmitriev, A. Y., Shilnikov, N. V., Ivanitskaya, E., & Pustovoytov, A. V. (2015) · Patologiya krovoobrashcheniya i kardiokhirurgiya · doi:10.21688/1681-3472-2014-4-113-122 · Cited by 1
“Данные работы показали существенное снижение спилловера норэпинефрина, в дополнение к снижению секреции ренина и увеличению почечного кровотока [49].”
Therapierefraktäre Hypertonie: Stellenwert neuer Therapiekonzepte
Siekierka-Harreis, M., Rump, L. C., & Vonend, O. (2012) · Der Internist · doi:10.1007/s00108-012-3134-2 · Cited by 1
Muscle Sympathetic Nerve Activity and Cardiovascular Disease
Joho, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-56012-8_3 · Cited by 1
Renal Sympathetic Denervation: a New Catheter in a New Scenario
Staico, R., Armaganijan, L., Moreira, D. A. R., Medeiros, P. T. J., Habib, R. G., Neto, J. M., & Abizaid, A. (2013) · Revista Brasileira de Cardiologia Invasiva (English Edition) · doi:10.1016/s2214-1235(15)30165-4 · Cited by 1
Staico, R., Armaganijan, L., Moreira, D. A. R., de Sousa, M. G., Borelli, F. A. D. O., Amodeo, C., Neto, J. M., Sousa, J. E., Sousa, A. G. M. R., & Abizaid, A. (2014) · Revista Brasileira de Cardiologia Invasiva · doi:10.1016/s0104-1843(14)50013-6 · Cited by 1
Jakopović, M. M., Ivošević, A., Stanković, M., & Prkačin, I. (2018) · Cardiologia Croatica · doi:10.15836/ccar2018.277 · Cited by 2
Руденко, Б. А., Анатольевна, Ф. Д., Vasiliev, D. K., Shukurov, F. B., Shanoyan, А. S., Мамедов, М. Н., & Drapkina, O. M. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-3139 · Cited by 1
What We Know and Don’t Know About Renal Denervation to Lower Blood Pressure
Chau, K. H.-Y., Azizi, M., & Kirtane, A. J. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0169 · Cited by 1
Renal Sympathetic Denervation: a New Catheter in a New Scenario
Staico, R., Armaganijan, L., Moreira, D. A. R., Medeiros, P. T. J., Habib, R. G., Neto, J. M., & Abizaid, A. (2013) · Revista Brasileira de Cardiologia Invasiva · doi:10.1016/s0104-1843(13)50072-5 · Cited by 1
Schlaich, M. P., & Sata, Y. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5223-1_22 · Cited by 1
Self-citationMechanical Interventional Therapies for Hypertension: Present Status and Future Prospects
Wong, E. T. Y., & Low, A. F.-H. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-95734-6_27 · Cited by 1
The Endpoint on Measuring the Clinical Effects of Renal Denervation: What Are the Best Surrogates
Sobotka, P. A., Harrison, D. G., & Fudim, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5223-1_4 · Cited by 1
Self-citationResponse to Blood Pressure and Sympathetic Nervous System Response to Renal Denervation
Heusser, K., Tank, J., Brinkmann, J., Schmidt, B. M. W., Menne, J., Klein, G. G., Bauersachs, J. K., Haller, H. G., Sweep, F. C. G. J., Diedrich, A., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.00520 · Cited by 1
Autonomic denervation and the origins of chronic Western diseases
Quinn, M. J. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.11.022 · Cited by 1
Heusser, K., Tank, J., Brinkmann, J., Schmidt, B. M. W., Menne, J., Klein, G. G., Bauersachs, J. K., Haller, H. G., Sweep, F. C. G. J., Diedrich, A., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.00497 · Cited by 1
Rebuttal from Esler, Lambert, and Schlaich
Esler, M., Lambert, É., & Schlaich, M. P. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00182.2010b · Cited by 2
Self-citationBurnier, M. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08411 · Cited by 1
Luft, F. C. (2014) · Kidney International · doi:10.1038/ki.2014.258 · Cited by 1
Emerging Therapies for Chronic Kidney Disease
Roy‐Chaudhury, P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00064-0
Chirurgische Techniken und interventionelle Techniken
Debus, E. S., & Gross-Fengels, W. (2012) · Springer eBooks · doi:10.1007/978-3-642-01709-4_10
Fallbericht: Frühe Blutdruckreaktion nach renaler Denervation
Bauer, A., Gerst, F., Sylejmani, X., & Jahn, L. A. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Staico, R., Armaganijan, L., Moreira, D. A. R., de Sousa, M. G., Borelli, F. A. D. O., Amodeo, C., Neto, J. M., Sousa, J. E., Sousa, A. G. M. R., & Abizaid, A. (2014) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/0104-1843000000013
“Dentre elas, enfatizamos: (1) a significativa variabilidade de dispositivos e técnicas, incluindo energia utilizada, nú mero de eletrodos e duração da ablação; (2) a real relevância da hiperatividade simpática na fisiopatologia da hipertensão resistente, visto que esta é uma doença multifatorial e que, em alguns casos…”
BackgroundRupp, V., & Britta, J. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Innovative Therapieoptionen bei therapieresistenter arterieller Hypertonie
Linnenweber-Held, S., Haller, H. G., & Menne, J. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
La denervazione renale nella ipertensione resistente
Coppola, G. M., Arienzo, F., Rossano, R., Apicella, L., Terribile, M., Coppola, M. M., & Maglione, M. (2018) · Giornale di Clinica Nefrologica e Dialisi · doi:10.33393/gcnd.2012.1171
Novel Approaches in Hypertension Treatment - Modulation of the Sympathetic Overactivity
Sebastian, A., Rump, L., & Vone, O. (2011) · InTech eBooks · doi:10.5772/19741
“There is a significant reduction in blood pressure and burst activity (modified from [77] ).”
BackgroundRenal Sympathetic Denervation in the Management of Treatment-Resistant Hypertension
Krum, H. (2014) · Springer eBooks · doi:10.1007/978-3-319-09162-4_17
Self-citationNierenarteriennervenablation bei therapieresistenter Hypertonie: Eine Bestandsaufnahme
Hausberg, M., Kisters, K., & Reinecke, H. (2013) · Der Nephrologe · doi:10.1007/s11560-012-0735-7
Denervação simpática renal: usando uma velha ferramenta para um novo trabalho?
Healey, J. S. (2013) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972013000100002
Renale sympathische Denervation als Ultima ratio in der Therapie des Bluthochdrucks
Hoffmann, R. (2013) · Nervenheilkunde · doi:10.1055/s-0038-1628500
“Mittels Radiotracer Dilutionstechnologie konnte an einem Patienten gezeigt werden, dass die Norepinephrin-Ausschüttung von den Nieren in die Zirkulation nach der Prozedur um fast 50% sank (5).”
BackgroundDenervación renal: Nueva herramienta para tratar la hipertensión arterial esencial resistente
Rodríguez, R., Vanzetto, G., & Bonnefoy‐Cudraz, E. (2013) · Anales de la Facultad de Ciencias Médicas (Asunción)
Unilateral renal denervation: Is the ‘fragmentary’ procedure ‘disabled’?
Xiao, Y., Zhou, S., & Liu, Q. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.210
“While unilateral procedure can do it, why bother performing bilaterally? In fact, due to the unknown safety profile, the RDN procedure was always performed unilaterally first during the initial phase of the firstin-man trial, and the other arterywas treated after 4 weeks [2].”
BackgroundInterindividuelle renale Sympathektomie zur Behandlung der therapieresistenten Hypertonie
Mahfoud, F., Kindermann, M., Ukena, C., Pa, S., Kindermann, I., Schlaich, M. P., & Böhm, M. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Self-citationNicht-medikamentöse Hypertoniebehandlungdurch Beeinflussung des autonomen Nervensystems
Schmidli, & Mohaupt, G. (2012) · Therapeutische Umschau · doi:10.1024/0040-5930/a000292
“Bereits jetzt gibt es Daten, dass Endorganbeteiligungen im Rahmen der arteriellen Hypertonie, insbesondere die linksventrikuläre Hypertrophie [12] regredient ist, aber auch günstige metabolische Ef fekte, u.”
BackgroundKhamis, H., & Abdeaziz, A. (2014) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2013.12.013
“Pathophysiological proof of concept of the denervation of the renal artery has also been shown in a small subset of patients.(16,17) Schlaich et al.”
BackgroundRenale Denervierung und Hypertonie: Ist nach Simplicity-3 alles vorbei?
Haller, H. G., Menne, J., Limbourg, F. P., & Schmidt, B. M. W. (2014) · Der Nephrologe · doi:10.1007/s11560-014-0874-0
New Hope for Resistant Hypertention
Rahman, Z., Karmaker, K., Ahmed, M., Aziz, M., Chowdhury, S., & Datta, B. (2012) · Cardiovascular Journal · doi:10.3329/cardio.v5i1.12278
Kimura, G. (2013) · Hypertension Research · doi:10.1038/hr.2013.117
What are the benefits of renal denervation in patients with resistant hypertension?
Roser, M., & Dorenkamp, M. (2013) · Interventional Cardiology · doi:10.2217/ica.13.5
Jordan, J., Heusser, K., Brinkmann, J., Schmidt, B. M. W., Menne, J., Klein, G. G., Bauersachs, J. K., Haller, H. G., Sweep, F. C. G. J., Diedrich, A., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.00577
Cagli, V., Manfellotto, D., & Stornello, M. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2012.79
New therapeutic option for therapy of refractory arterial hypertension: renal denervation
Dörr, O., Möllmann, H., Hamm, C. W., & NEF, H. M. (2012) · Interventional Cardiology · doi:10.2217/ica.12.36
Renal sympathetic denervation for resistant , hypertension--a novel treatment strategy.
Manakshe, G. V., CHAKRAVARTHI, C. K., Kiran, R., Menon, R. V., Hygriv Rao, B., Kumar, A., & Narasimhan, C. (2013) · PubMed
11th International Symposium on Mechanisms of Vasodilation
Amstein, R., Lüscher, T. F., & Vanhoutte, P. M. (2013)
Diseases The Carotid Body as a Therapeutic Target for the Treatment of Sympathetically Mediated
Ratcliffe, L. E. K., Nightingale, A. K., Abdala, A. P., Gourine, A. V., Mel, L. O. B. O., Patel, N. K., Sobotka, P. A., Fudim, M., Engelman, Z. J., & Fiona, D. (2013)
Self-citationCatheter-Based Renal Sympathetic Denervation for Resistant Hypertension: A Meta-
Garcia, A., Yuri, F., Macedo, B., Aziz, E. F., Herzog, E., & De, E. (2013)
Treatment Strategies for Resistant Arterial
Himmel, F., Ukena, C., & Schunkert, H. (2011)
Novel Pharmacological Approaches in Hypertension Treatment
Lerma, E. V., & Bakris, G. L. (2012) · Humana Press eBooks · doi:10.1007/978-1-60327-357-2_14
“In addition to the aforementioned direct effects of the procedure, it is also important to note that renal denervation decreased renin secretion by about 50% [ 26, 27 ] .”
BackgroundRenal Sympathetic Denervation: Using an Old Tool for a New Job?
Healey, J. S. (2013) · Revista Brasileira de Cardiologia Invasiva (English Edition) · doi:10.1016/s2214-1235(15)30095-8
Role of the Renal Nerves in Hypertension
Foss, J. D. (2014) · University of Minnesota Digital Conservancy (University of Minnesota)
Renal artery denervation: modulation of the autonomic nervous system to treat atrial fibrillation
Pokushalov, E. A., & Steinberg, J. S. (2015) · Wiley eBooks · doi:10.1002/9781118658369.ch19
Renal denervation – a novel method for the treatment of resistant hypertension
Kądziela, J., Florczak, E., Januszewicz, A., & Witkowski, A. (2010) · Advances in Interventional Cardiology · doi:10.5114/pwki.2010.17631
Sodha, N. R., Moore, H. J., Papademetriou, V., & Trachiotis, G. D. (2012) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1097/imi.0b013e31827ccd90
“Given the relative sizes of the ablation electrode and the lumen diameter, detailed attention to intraluminal lesion delivery is important to prevent stenosis and vascular endothelial injury(57) A round, circular lesion can result in postnecrotic stenosis, whereas sequential segmental lesions, as was used in the Sympl…”
BackgroundL’ablazione dei nervi renali: una prospettiva reale nella cura delle ipertensioni resistenti?
Cagli, V., Manfellotto, D., & Stornello, M. (2012) · Italian Journal of Medicine · doi:10.1016/j.itjm.2011.09.008
“[9] Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD.”
BackgroundInfluentialRenal denervation: an ‘upstream therapy’ for metabolic disease?
Thomopoulos, C., Tsioufis, C. P., Kotoulas, G., Kardoulas, D. G., & Makris, T. K. (2013) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000012
Controlling Blood Pressure without Drugs – Developing New Strategies
Schlaich, M. P., & Esler, M. (2011) · Asia Pacific Cardiology · doi:10.15420/apc.2011:3:1:37 · Cited by 2
Self-citationEn oppdatering på renal denervasjon som behandling av terapiresistent hypertensjon
Mariampillai, J. E. (2014) · NVA (Nasjonalt vitenarkiv)
So wird sie doch noch behandelbar: „Therapierefraktäre“ arterielle Hypertonie
Weil, J., & Schunkert, H. (2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-0365-z
Catheter-based Renal Sympathetic Denervation for Cardiovascular Diseases.
Fukuta, H., & Kimura, G. (2011) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.100.2289 · Cited by 1
Siagian, M., Ferly, A., Irianti, A., Kurniati, A., Low, F., & Riza, R. A. (2014) · Acta medica Indonesiana
Renal Reflexes and Denervation in Heart Failure
Pieruzzi, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-24993-3_13
Effects of Renal Denervation on Sympathetic Nervous System Activity
Seravalle, G., Brambilla, G., & Grassi, G. M. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-34141-5_20 · Cited by 1
Hoogerwaard, A. F., & Elvan, A. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.11.024 · Cited by 1
Interventionelle Therapiestrategien bei resistenter Hypertonie
Haller, H. G. (2011)
Renal Sympathetic Ablation Using an Irrigated-Tip Catheter: An Attractive Option?
Staico, R., Armaganijan, L., Dietrich, C. D. O., Abizaid, A., Moreira, D. A. R., Lópes, R. D., de Almeida, J. S., & Franco, M. (2013) · Revista Brasileira de Cardiologia Invasiva (English Edition) · doi:10.1016/s2214-1235(15)30097-1
Lansdown, A. (2016) · ORCA Online Research @Cardiff (Cardiff University)
Interventional management of hypertension
Khanna, N. N., & Rao, S. (2017) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2017.06.015
Renal artery sympathetic nerve radiofrequency denervation
Bartuś, K., Sadowski, J., Kapelak, B., Litwinowicz, R. A., Podolec, J., Bartuś, M., Dziewierz, A., Bartuś, S., Zajdel, W., & Lakkireddy, D. (2017) · Kardiologia Polska · doi:10.5603/kp.a2017.0100
“Improvement of glucose tolerance has also been confirmed by other authors [22, 23].”
ResultSympathektomie in der Gefäßmedizin
Bürger, T. (2020) · Springer Reference Medizin · doi:10.1007/978-3-662-53380-2_36
Does renal denervation lower sympathetic activity?
Blankestijn, P. J. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx217
Rocha‐Singh, K. J., Goswani, N. J., Kolluri, R., & Goldstein, J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2358-8.00041-3
Renal sympathetic ablation - new approach of hypertension therapy
Paulo, J. F. L. F. D. C. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/81q8-f671
Renal denervation on life support?
Ambrose, J. A. (2014) · Revista Argentina de Cardioangiología Intervencionista · doi:10.30567/raci/201402/0118-0119
Sleep Disturbances/Sleep Apnea
Parati, G., Lombardi, C., Narkiewicz, K., Wolf, J., & Ochoa, J. E. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_18
Renal Denervation in Resistant Hypertension
Coppola, G. M., Arienzo, F., Rossano, R., Apicella, L., Terribile, M., Coppola, M. M., & Maglione, M. (2012) · Giornale di Techniche Nefrologiche e Dialitiche · doi:10.1177/039493621202400405
Renal denervation in patient with resistant hypertension: A case report
Bošković, S., Sagić, D., Antonic, Z. D., Tasić, N., & Otašević, P. (2012) · Srce i krvni sudovi · doi:10.5937/siks1201012b
(Prediction of long-term renal denervation efficacy)
Kvasnička, J., Lambert, L., Waldauf, P., Zelinka, T., Petrák, O., Štrauch, B., Holaj, R., Indra, T., Krátká, Z., Klímová, J., et al. (2018) · Cor et Vasa · doi:10.1016/j.crvasa.2018.09.007
Krum, H., Schlaich, M. P., & Sobotka, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2766-1.00025-9
Self-citationPishva, S. R. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.122225
Tsioufis, K. P., Iliakis, P., & Kasiakogias, A. (2019) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-93320-7_24
Device-based Therapies for Hypertension
Cohen, D. L. (2016) · Hypertension Journal · doi:10.5005/jp-journals-10043-0050
Spadaro, A. G. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-16102019-104545
Trial designs and the evaluation of interventions for stable angina
Thompson, D. M. (2018) · Spiral (Imperial College London) · doi:10.25560/66163
Editorial commentary: Renal denervation: The three stages of academic grief
Howard, J. P. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.05.014
Metadata
- Authors
- Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., & Esler, M. D.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- University of Oklahoma Health Sciences Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-08-27
- Volume
- 361
- Issue
- 9
- Pages
- 932-934
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1994487234
- Cited by
- 772
- References
- 5
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 19 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 19 · 2019: 27 · 2018: 31 · 2017: 42 · 2016: 42 · 2015: 52 · 2014: 115 · 2013: 136 · 2012: 95
- FWCI
- 42.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- uncontrolled hypertension, bevacizumab, hereditary hemorrhagic telangiectasia, pulmonary arteriovenous malformation, intermittent dosing, long-term drug safety, iron requirements
- MeSH terms
- Humans, Hypertension, Kidney, Male, Middle Aged, Norepinephrine, Renal Artery, Sympathectomy, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.